Enhancing the Development of New Regenerative Medicine Therapies:Proposal to Build a Robust Clinical Research Development and Data Hub
加强再生医学新疗法的开发:建立强大的临床研究开发和数据中心的提案
基本信息
- 批准号:10004930
- 负责人:
- 金额:$ 88.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-27 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAreaCardiovascular DiseasesCell TherapyCellsCenter for Translational Science ActivitiesClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCollectionCommon Data ElementCommunicationDataData Coordinating CenterData SetDevelopmentDiseaseEducational workshopElectronic Health RecordEnsureFosteringGrowthHealthHeart failureHumanIndividualInfrastructureInvestigationLeadershipLinkLongterm Follow-upManualsMicroRNAsNatural regenerationOnline SystemsOperative Surgical ProceduresOrganOutcomeParticipantPatientsProceduresProcessRegenerative MedicineRegistriesReportingReproducibilityResearchResearch PersonnelResearch SupportResourcesRitalinSecureStem cellsTherapeuticTherapy trialTimeTissue EngineeringTissuesUnited States National Institutes of HealthVisionWorkadministrative databaseadult stem cellbasecatalystcell injurycloud baseddata hubdata managementdata sharingdesignelectronic dataexosomeinnovationinterestinternational centerinvestigator trainingmultidisciplinarynervous system disordernovel therapeuticspre-clinicalpreclinical studyrepairedrepositoryresearch and developmenttoolweb-based tool
项目摘要
No abstract provided
未提供摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH E FINKELSTEIN其他文献
JOSEPH E FINKELSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH E FINKELSTEIN', 18)}}的其他基金
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
肺康复综合健康信息学参与框架
- 批准号:
10469454 - 财政年份:2018
- 资助金额:
$ 88.42万 - 项目类别:
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
肺康复综合健康信息学参与框架
- 批准号:
10026347 - 财政年份:2018
- 资助金额:
$ 88.42万 - 项目类别:
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
肺康复综合健康信息学参与框架
- 批准号:
10833840 - 财政年份:2018
- 资助金额:
$ 88.42万 - 项目类别:
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
肺康复综合健康信息学参与框架
- 批准号:
10256022 - 财政年份:2018
- 资助金额:
$ 88.42万 - 项目类别:
Comprehensive Informatics Framework for CER Dissemination
CER 传播的综合信息学框架
- 批准号:
8009265 - 财政年份:2010
- 资助金额:
$ 88.42万 - 项目类别:
Hypertension Telemanagement in African Americans
非裔美国人的高血压远程管理
- 批准号:
7261897 - 财政年份:2004
- 资助金额:
$ 88.42万 - 项目类别:
Hypertension Telemanagement in African Americans
非裔美国人的高血压远程管理
- 批准号:
7092538 - 财政年份:2004
- 资助金额:
$ 88.42万 - 项目类别:
Hypertension Telemanagement in African Americans
非裔美国人的高血压远程管理
- 批准号:
7216079 - 财政年份:2004
- 资助金额:
$ 88.42万 - 项目类别:
Hypertension Telemanagement in African Americans
非裔美国人的高血压远程管理
- 批准号:
7460875 - 财政年份:2004
- 资助金额:
$ 88.42万 - 项目类别:
Hypertension Telemanagement in African Americans
非裔美国人的高血压远程管理
- 批准号:
6846716 - 财政年份:2004
- 资助金额:
$ 88.42万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 88.42万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 88.42万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 88.42万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 88.42万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 88.42万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 88.42万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 88.42万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 88.42万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 88.42万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 88.42万 - 项目类别: